[HTML][HTML] Induced sputum metabolomic profiles and oxidative stress are associated with chronic obstructive pulmonary disease (COPD) severity: potential use for …
Chronic obstructive pulmonary disease (COPD) is a highly heterogeneous disease, and
metabolomics plays a hub role in predictive, preventive, and personalized medicine (PPPM) …
metabolomics plays a hub role in predictive, preventive, and personalized medicine (PPPM) …
Plasma metabolomics and lipidomics reveal perturbed metabolites in different disease stages of chronic obstructive pulmonary disease
Background Chronic obstructive pulmonary disease (COPD) is a common disease
characterized by persistent respiratory symptoms and airflow restriction. It is usually …
characterized by persistent respiratory symptoms and airflow restriction. It is usually …
[HTML][HTML] Metabolomics and transcriptomics pathway approach reveals outcome-specific perturbations in COPD
CI Cruickshank-Quinn, S Jacobson, G Hughes… - Scientific reports, 2018 - nature.com
Chronic obstructive pulmonary disease (COPD) comprises multiple phenotypes such as
airflow obstruction, emphysema, and frequent episodes of acute worsening of respiratory …
airflow obstruction, emphysema, and frequent episodes of acute worsening of respiratory …
[HTML][HTML] An updated overview of metabolomic profile changes in chronic obstructive pulmonary disease
N Ran, Z Pang, Y Gu, H Pan, X Zuo, X Guan, Y Yuan… - Metabolites, 2019 - mdpi.com
Chronic obstructive pulmonary disease (COPD), a common and heterogeneous respiratory
disease, is characterized by persistent and incompletely reversible airflow limitation …
disease, is characterized by persistent and incompletely reversible airflow limitation …
A novel metabolic score for predicting the acute exacerbation in patients with chronic obstructive pulmonary disease
L Peng, H You, M Xu, Z Dong, M Liu… - International Journal of …, 2023 - Taylor & Francis
Background Chronic obstructive pulmonary disease (COPD) has higher mortality when
developing to acute exacerbation (AECOPD); hence, the early intervention of COPD is …
developing to acute exacerbation (AECOPD); hence, the early intervention of COPD is …
Multi-omics study on biomarker and pathway discovery of chronic obstructive pulmonary disease
Y Tang, Z Chen, Z Fang, J Zhao, Y Zhou… - Journal of Breath …, 2021 - iopscience.iop.org
Chronic obstructive pulmonary disease (COPD) is a common heterogeneous respiratory
disease characterized by persistent and incompletely reversible airflow limitation. Due to the …
disease characterized by persistent and incompletely reversible airflow limitation. Due to the …
[HTML][HTML] Metabolome features of COPD: a scoping review
S Godbole, RP Bowler - Metabolites, 2022 - mdpi.com
Chronic obstructive pulmonary disease (COPD) is a complex heterogeneous disease state
with multiple phenotypic presentations that include chronic bronchitis and emphysema …
with multiple phenotypic presentations that include chronic bronchitis and emphysema …
Identification of sputum biomarkers predictive of pulmonary exacerbations in COPD
Background Improved understanding of the pathways associated with airway
pathophysiologic features in COPD will identify new predictive biomarkers and novel …
pathophysiologic features in COPD will identify new predictive biomarkers and novel …
Integrating 3-omics data analyze rat lung tissue of COPD states and medical intervention by delineation of molecular and pathway alterations
J Li, P Zhao, L Yang, Y Li, Y Tian, S Li… - Bioscience reports, 2017 - portlandpress.com
Chronic obstructive pulmonary disease (COPD) is a serious health problem. However, the
molecular pathogenesis of COPD remains unknown. Here, we explored the molecular …
molecular pathogenesis of COPD remains unknown. Here, we explored the molecular …
[HTML][HTML] Bronchoalveolar lavage fluid from COPD patients reveals more compounds associated with disease than matched plasma
E Halper-Stromberg, L Gillenwater… - Metabolites, 2019 - mdpi.com
Smoking causes chronic obstructive pulmonary disease (COPD). Though recent studies
identified a COPD metabolomic signature in blood, no large studies examine the …
identified a COPD metabolomic signature in blood, no large studies examine the …